Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR9 | Q9NR96 | 8/20 | 0.44 |
| ▸ | TLR7 | Q9NYK1 | 7/20 | 0.43 |
| ▸ | PDE2A | O00408 | 3/20 | 0.43 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.43 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.43 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.43 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | XDH | P47989 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16815297 | 0.93 | TLR9 (0.43) | TLR9TLR7PDE2APDE3BPDE3A | |
| SCHEMBL16815230 | 0.92 | PDE2A (0.49) | TLR9TLR7PDE2APDE3BPDE3A | |
| SCHEMBL20057582 | 0.88 | MAPT (0.48) | TLR9TLR7PDE2APDE3BPDE3A | |
| SCHEMBL16848751 | 0.88 | F2RL3 (0.38) | TLR9TLR7PDE2APDE3BPDE3A | |
| SCHEMBL20057418 | 0.86 | TLR9 (0.43) | TLR9TLR7PDE2APDE3BPDE3A | |
| SCHEMBL16848748 | 0.85 | S1PR1 (0.38) | PDE3AMAOASMN1; SMN2 | |
| Betaine SCHEMBL16817835 | 0.85 | TLR7 (0.43) | TLR9TLR7PDE2APDE3BPDE3A | |
| Glycinebetaine SCHEMBL16817774 | 0.85 | TLR7 (0.38) | TLR9TLR7PDE2APDE3BPDE3A | |
| SCHEMBL16848781 | 0.85 | TLR9 (0.41) | TLR9TLR7PDE3BPDE3AP2RY12 | |
| SCHEMBL16815239 | 0.84 | HDAC6 (0.48) | TLR7POLBMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9453010-B2 | Marker dyes for UV and short wave excitation with high stokes shift based on benzoxazoles | DYOMICS GMBH (DE) | 2016-09-27 | — | — | US | disclosed |
| US-20150175591-A1 | MARKER DYES FOR UV AND SHORT WAVE EXCITATION WITH HIGH STOKES SHIFT BASED ON BENZOXAZOLES | DYOMICS GMBH (DE) | 2015-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150175591-A1 | MARKER DYES FOR UV AND SHORT WAVE EXCITATION WITH HIGH STOKES SHIFT BASED ON BENZOXAZOLES | NR2E3, H1-10, NR0B1 | TLR9 368/4885TLR7 525/4885PDE2A 4848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.